home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Antibody Design and Discovery • Jun 07-08, 2012 • San Diego, CA, USA

 
  March 09, 2012  
     
 
GTCbio, San Diego
2012-03-09


GTC is proud to present the Antibody Design and Discovery Conference on June 7-8, 2012 at the Hilton San Diego Resort & Spa in San Diego, CA!

At the Antibody Design and Discovery Conference, leading industry and academic innovators will discuss exciting clinical trends and applications of antibodies. We’ll explore novel technologies being utilized to identify and select antibodies with better accuracy and efficiency, and learn about new optimization and developability techniques to enhance effective function. Moreover, attendees will hear directly from scientists and researchers about emerging clinical data, and its implications for the advancement of the field, including therapeutic antibodies in cancer, and infectious and autoimmune diseases.

Session Topics

Improving Antibody Discovery and Selection Techniques

Novel Sequencing Techniques, Computational Discovery

Library Characterization

In Vitro Discovery & Selection
Optimization Strategies: Enhancing Effective Function

Epitope Mapping, Increasing Antigen Binding & Affinity

Purification Systems

Small Particles & Fragments, Solubility

Antibody Drug Conjugates

Bispecific/ Bifunctional Antibodies, Multispecific Antibodies

Fc Engineering, Half Life Enhancement

Recombinant Antibodies, Fusions

Biosimilar Design and Efficacy
Novel Advances in Therapeutic Antibodies

Developability in the areas of Cancer, Infectious Diseases, Autoimmune Diseases

 

This conference is also part of the Drug Discovery and Regulatory Summit, which consists of this track and three other tracks: 
                Biospecimens and Biorepositories
                6th Drug Design and Medicinal Chemistry
                Life Science Legal & Business Strategy

 

Conference Date: June 7-8, 2012 

Venue: San Diego , CA, USA      1775 East Mission Bay Drive | San Diego, CA 92109

Event Link: http://www.gtcbio.com/index.php?option=com_conference&file=home&cn=Antibody%20Design%20and%20Discovery&cid=84

 
 
Organized by: GTCbio
Invited Speakers:

 

DISTINGUISHED SPEAKERS
 

Javier Chaparro- Riggers, Principle Scientist, Protein Engineering, Rinat Laboratories, Pfizer GRD

Ho Sung Cho, Chief Technology Officer, Ambrx

Dimiter Dimitrov, Senior Investigator, Head, Protein Interaction Group, NCI, NIH

William Finlay, Director, Protein Discovery and Optimization, BioTx, Pfizer WRD

Jacob Glanville, Principle Scientist, Protein Generation Unit, Rinat Laboratories, Pfizer GRD

Jacquelyn Hank, Research Professor, Human Oncology, University of Wisconsin

Brantley Herrin, Assistant Professor, Pathology and Laboratory Medicine, Emory University

David Hilbert, Chief Scientific Officer, Head of Research and Development, Zyngenia

Azad Kaushik, Associate Professor, Immunology, University of Guelph

David King, Chief Scientific Officer, AnaptysBio

Olivier Laurent, Director, Protein Science, CovX Research, Pfizer WRD

Benfang Lei, Assistant Professor, Veterinary Molecular Biology, Montana State University

Nancy Levin, Director, Biology, CovX Research, Pfizer WRD

Giovanni Magistrelli, Head, Protein Generation Unit, Novimmune

John Mascola, Deputy Director, Vaccines Research Center, NIAID, NIH

David Meininger, Senior Director, Biologics Discovery, Merck

Jim Mo, Research Fellow, Pfizer

Robert Rush, Emeritus Professor, Human Physiology, Flinders University

William Schief, Associate Professor, Immunology and Microbial Science, The Scripps Research Institute

Jan Schnitzer, Director, Professor, Cellular and Molecular Biology, Proteogenomics Research Institute for Systems Medicine (PRISM)

Vaughn Smider, Assistant Professor, Molecular Biology, The Scripps Research Institute

Charles Theuer, President, Chief Executive Officer, TRACON Pharma

Mohit Trikha, Chief Scientific Officer, Vice President, Early Development, 
Triphase Accelerator

Edmond Yunis, Professor, Pathology; Chief, Immunogenetics, Harvard Medical School; Dana-Farber Cancer Institute

 

 
Deadline for Abstracts: 2012-06-08
 
Registration: https://www.gtcbio.com/index.php?option=com_register&cn=Antibody%20Design%20and%20Discovery&cid=84
E-mail: ken.lin@gtcbio.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.